Technology ❯ Artificial Intelligence ❯ Applications ❯ Healthcare

Drug Development

Novo Nordisk Partners With OpenAI to Speed Drug Development and Operations

Pilots begin now toward a company-wide rollout by end-2026 under strict data governance.

FDA Introduces Elsa AI to Fast-Track Drug and Device Approvals